Madrid, Spain.
La olfato loss no solo is one of the factors of diagnostic temprano de la covid-19, also is a prognostic buenoma syndrome of the nurse, following an international investigation conducted by scientists from the Complutense University and the San Carlos Clinic de Madrid.
Travels of a study conducted in several centers, with the mayor used recently (5,868 patients admitted) the investigators investigating that even if their origin is a mystery, the anosmia olfato loss– can act as a prognostic buen factor of the disease.
LEA: Netherlands suspends AstraZeneca vacancy by pre-occupation
“These results have ten many implications, from the initial evaluation of patients has the capacity to understand physiopathology. Possibly, the invasion of the nasal epithelium has an active immune system that prevents them from cytoquine torments”, Verklaring Jesús Porta-Etessam, Head of the Department of Neurology at the San Carlos Clinical Hospital, Professor of the Faculty of Medicine at the University of Madrid (UCM) and first author of the work.
También: Florida can host a general public holiday in April
In addition to identifying the anosmia as a prognostic good factor, the researchers also determined that the olfactory and palatable dysfunctions are most frequent in females (12.41% before 8.67%), at least 65 years and in patients with pathologies of rhinitis, pulmonary, coronary, neurological and oncological.
Classify patients
The results obtained on one of los síntomas more coronavirus strains can serve as a criterion for the classification of patients’ tumors therapeutic decisions, said the University of Madrid Completely on a different note this month.
The conclusions of this state may serve to elaborate “risk indices” of complication, which the Porta-Etessam series is very useful and interesting to watch, treat or appreciate the high of patients.
In the study he participated, in addition to the UCM and the San Carlos Clinic, the Madrileños hospitals of La Paz, Infanta Sofía, Nuestra Senñora de América, Puerta de Hierro or Getafe; the University Hospital Clínico de Valladolid (north of Spain), Virgen de La Arraixaca (Murcia) -sureste- Álvaro Cunqueiro (Vigo) -noroeste- and el de Burgos (north); the Institute of Cardiology and Cardiovascular Surgery of Habana (Cuba); the General Hospital del Norte de Guayaquil IESS Los Ceibos (Ecuador) o la Clinique San Carlo de Milán (Italia). EFE